營養生活女性美妍維他命
Lingua del testo originale non specificata dalla fonte.
營養生活女性美妍維他命 : Prodotto registrato a Taiwan. Questa registrazione non costituisce un’autorizzazione alla vendita in Francia o nell’Unione europea. Non dimostra la sicurezza o l’efficacia del prodotto.
TFDA, registri taiwanesi di compresse, capsule e prodotti di nutrizione medica, consultato il 27 ottobre 2026.
Taiwan Food and Drug Administration (TFDA), Open Government Data License, versione 1.0
Testo originale in inglese.
La categoria del registro estero non determina la categoria normativa del prodotto in Francia.
Riferimenti francesi ed europei per gli ingredienti riconosciuti
Nessun punto rilevato dalle regole applicate agli ingredienti riconosciuti.
Gli ingredienti non identificati non vengono valutati. L’assenza di segnali non dimostra la conformità del prodotto.
Composizione pubblicata
| Ingrediente pubblicato | Testo e quantità pubblicati | Nutriente o sostanza identificati |
|---|---|---|
| VITAMIN A (RETINYL ACETATE) | VITAMIN A (RETINYL ACETATE) | Vitamine A |
| BETA CAROTENE | BETA CAROTENE | Bêta-carotène |
| VITAMIN C (ASCORBIC ACID) | VITAMIN C (ASCORBIC ACID) | Vitamine C |
| VITAMIN D3 (CHOLECALCIFEROL) | VITAMIN D3 (CHOLECALCIFEROL) | Vitamine D |
| VITAMIN E (D-ALPHA TOCOPHERYL ACETATE) | VITAMIN E (D-ALPHA TOCOPHERYL ACETATE) | Vitamine E |
| VITAMIN K1 (PHYLLOQUINONE) | VITAMIN K1 (PHYLLOQUINONE) | Vitamine K |
| VITAMIN B1 (THIAMINE MONONITRATE) | VITAMIN B1 (THIAMINE MONONITRATE) | Vitamine B1 (thiamine) |
| VITAMIN B2 (RIBOFLAVIN) | VITAMIN B2 (RIBOFLAVIN) | Vitamine B2 (riboflavine) |
| NICOTINAMIDE | NICOTINAMIDE | Nicotinamide (vitamine B3) |
| VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE) | VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE) | Vitamine B6 |
| FOLIC ACID | FOLIC ACID | Folates (vitamine B9) |
| VITAMIN B12 (CYANOCOBALAMIN) | VITAMIN B12 (CYANOCOBALAMIN) | Vitamine B12 |
| BIOTIN | BIOTIN | Biotine (vitamine B8) |
| CALCIUM PANTOTHENATE | CALCIUM PANTOTHENATE | Acide pantothénique (vitamine B5) |
| CALCIUM CARBONATE | CALCIUM CARBONATE | Calcium |
| FERROUS FUMARATE | FERROUS FUMARATE | Fer |
| POTASSIUM IODIDE | POTASSIUM IODIDE | Iode |
| MAGNESIUM OXIDE | MAGNESIUM OXIDE | Magnésium |
| ZINC OXIDE | ZINC OXIDE | Zinc |
| SELENIUM YEAST | SELENIUM YEAST | Sélénium |
| COPPER SULFATE | COPPER SULFATE | Cuivre |
| MANGANESE SULFATE | MANGANESE SULFATE | Manganèse |
| CHROMIUM YEAST | CHROMIUM YEAST | Chrome |
| MOLYBDENUM YEAST | MOLYBDENUM YEAST | Molybdène |
| SODIUM CITRATE | SODIUM CITRATE | Non identificato |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | Potassium |
| CHOLINE BITARTRATE | CHOLINE BITARTRATE | Non identificato |
| INOSITOL | INOSITOL | Inositol |
| CITRUS BIOFLAVONOIDS | CITRUS BIOFLAVONOIDS | Non identificato |
| BEE POLLEN | BEE POLLEN | Non identificato |
| ROYAL JELLY | ROYAL JELLY | Gelée royale |
| ANGELICAE SINENSIS RADIX EXTRACT | ANGELICAE SINENSIS RADIX EXTRACT | Non identificato |
| MALTODEXTRIN | MALTODEXTRIN | Maltodextrine |
| SILICON DIOXIDE | SILICON DIOXIDE | Non identificato |
| GARLIC | GARLIC | Non identificato |
| METHYL HESPERIDIN | METHYL HESPERIDIN | Non identificato |
| RASPBERRY LEAVES EXTRACT | RASPBERRY LEAVES EXTRACT | Non identificato |
| CRANBERRY | CRANBERRY | Non identificato |
| RED CLOVER | RED CLOVER | Non identificato |
| WILD YAM | WILD YAM | Non identificato |
| CHASTE BERRY EXTRACT | CHASTE BERRY EXTRACT | Non identificato |
| CAMOMILE FLOWER CONCENTRACT EXTRACT | CAMOMILE FLOWER CONCENTRACT EXTRACT | Non identificato |
| SOY PROTEIN EXTRACT POWDER | SOY PROTEIN EXTRACT POWDER | Non identificato |
| BARLEY GRASS | BARLEY GRASS | Non identificato |
| COENZYME Q10 | COENZYME Q10 | Ubiquinone |
| PINE BARK EXTRACT | PINE BARK EXTRACT | Non identificato |
| TOMATO | TOMATO | Non identificato |
| MICROCRYSTALLINE CELLULOSE | MICROCRYSTALLINE CELLULOSE | Non identificato |
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | Non identificato |
| STEARIC ACID | STEARIC ACID | Acide stéarique |
| ALLURA RED AC | ALLURA RED AC | Non identificato |
I dati importati non forniscono una posologia giornaliera utilizzabile. Non viene stimata alcuna dose giornaliera né effettuato alcun confronto con i limiti di dose. Una quantità pubblicata può riferirsi a una preparazione o a un’unità non precisata. I nomi cinesi sono conservati senza traduzione.
Scheda del prodotto
- Numero di registrazione
- 1106601335
- Nome cinese
- 營養生活女性美妍維他命
- Nome inglese
- NUTRITION LIFE WOMAN BEAUTY+ VIT TABLETS
- Tipo
- Compresse e capsule importate
- Stato pubblicato
- Stato non fornito in questa esportazione; la data di validità è indicata separatamente
- Titolare
- 營養生活健康有限公司
- Data di registrazione
- 2021-04-06
- Fine della validità pubblicata
- 2031-04-06
Dati originali del registro
Consultare i campi pubblicati e le loro varianti
- Nome del prodotto
- 營養生活女性美妍維他命
- Ingredienti attivi
- VITAMIN A (RETINYL ACETATE);;BETA CAROTENE;;VITAMIN C (ASCORBIC ACID);;VITAMIN D3 (CHOLECALCIFEROL);;VITAMIN E (D-ALPHA TOCOPHERYL ACETATE);;VITAMIN K1 (PHYLLOQUINONE);;VITAMIN B1 (THIAMINE MONONITRATE);;VITAMIN B2 (RIBOFLAVIN);;NICOTINAMIDE;;VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE);;FOLIC ACID;;VITAMIN B12 (CYANOCOBALAMIN);;BIOTIN;;CALCIUM PANTOTHENATE;;CALCIUM CARBONATE;;FERROUS FUMARATE;;POTASSIUM IODIDE;;MAGNESIUM OXIDE;;ZINC OXIDE;;SELENIUM YEAST;;COPPER SULFATE;;MANGANESE SULFATE;;CHROMIUM YEAST;;MOLYBDENUM YEAST;;SODIUM CITRATE;;POTASSIUM CHLORIDE;;CHOLINE BITARTRATE;;INOSITOL;;CITRUS BIOFLAVONOIDS;;BEE POLLEN;;ROYAL JELLY;;ANGELICAE SINENSIS RADIX EXTRACT;;MALTODEXTRIN;;SILICON DIOXIDE;;GARLIC;;METHYL HESPERIDIN;;RASPBERRY LEAVES EXTRACT;;MALTODEXTRIN;;SILICON DIOXIDE;;CRANBERRY;;RED CLOVER;;WILD YAM;;CHASTE BERRY EXTRACT;;MALTODEXTRIN;;SILICON DIOXIDE;;CAMOMILE FLOWER CONCENTRACT EXTRACT;;MALTODEXTRIN;;SILICON DIOXIDE;;SOY PROTEIN EXTRACT POWDER;;BARLEY GRASS;;COENZYME Q10;;PINE BARK EXTRACT;;MALTODEXTRIN;;SILICON DIOXIDE;;TOMATO;;MICROCRYSTALLINE CELLULOSE;;MAGNESIUM STEARATE;;STEARIC ACID;;SILICON DIOXIDE;;ALLURA RED AC;;
- Fine validità
- 1200406
- Numero di registrazione
- 1106601335
- Titolare
- 營養生活健康有限公司
- Data di registrazione
- 1100406
- Riferimento pubblicato
- DHC0B066013352
- Nome inglese pubblicato
- NUTRITION LIFE WOMAN BEAUTY+ VIT TABLETS
Fonte ufficiale
Consultare il registro ufficiale, numero 1106601335
Taiwan Food and Drug Administration (TFDA), Open Government Data License, versione 1.0
Open Government Data License, version 1.0
Avvertenze ufficiali (Health Canada)
Health Canada pubblica avvertenze su questi ingredienti:
- VITAMIN D3 (CHOLECALCIFEROL)
Leggere l'avvertenza, quando si applica e gli studi citati
Testo originale ufficiale in inglese.
VITAMIN D (>1,000 - 2,500 IU)
Via di somministrazione: Oral
Precauzioni e avvertenze
Condizione di applicazione: All products except products containing zinc sourced from picolinate requiring a contraindication.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Condizione di applicazione: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney disorders (NIH 2024; BfR 2020).
Fonti citate da Health Canada (2)
- BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
- NIH 2024: National Institute of Health: Vitamin D Fact Sheet for Health Professionals; 2024. [Accessed 2026 March 18]. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking other supplements or products containing vitamin D or vitamin D analogues.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking any medications including antacids, anticonvulsants, digoxin, cholestyramine, colestipol, mineral oil, steroids, statins or thiazide diuretics (NNHPD 2021; BfR 2020).
Fonti citate da Health Canada (3)
- BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
- NNHPD 2021. Natural and Non-Prescription Health Products Directorate. Internal evidence and HC's product monographs.
- DPSNSO 2021. Direction des produits de santé naturels et sans ordonnance. Preuves internes et monographies de produits internes de SC.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to determine if you would benefit from additional vitamin D as 15-20 mcg (600-800 IU) of vitamin D per day is an adequate quantity for most individuals.
Si applica ai prodotti: containing vitamin K2.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (NNHPD 2026).
Fonti citate da Health Canada (2)
- NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
- DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre
Si applica ai prodotti: providing 25-34 mg of zinc per day for adults 18 years or 31-50 mg of zinc per day for adults 19 years and older.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are unsure whether you are taking enough copper as zinc supplementation can cause a copper deficiency (NNHPD 2026).
Fonti citate da Health Canada (2)
- NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
- DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre
Controindicazioni
Condizione di applicazione: All products.
Do not use if you have hypercalcemia and/or hypercalciuria (NIH 2024; BfR 2020).
Fonti citate da Health Canada (2)
- BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
- NIH 2024: National Institute of Health: Vitamin D Fact Sheet for Health Professionals; 2024. [Accessed 2026 March 18]. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/
Si applica ai prodotti: containing zinc sourced from picolinate.
Do not use if you are pregnant or breastfeeding (NNHPD 2026).
Fonti citate da Health Canada (2)
- NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
- DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre
Reazioni avverse note
Condizione di applicazione: All products.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if the following early symptoms of hypercalcemia occur: weakness, fatigue, drowsiness, headache, lack of appetite, dry mouth, metallic taste, nausea, vomiting, vertigo, ringing in the ears, lack of coordination and muscle weakness or if you develop any other symptom (NIH 2024; BfR 2020).
Fonti citate da Health Canada (2)
- BfR 2020: Vitamin D: consumption of high-dose food supplements is unnecessary; BfR Opinion No 035; 2020. [Accessed 2026March 18]. Available from: https://www.bfr.bund.de/cm/349/vitamin-d-consumption-of-high-dose-food-supplements-is-unnecessary.pdf
- NIH 2024: National Institute of Health: Vitamin D Fact Sheet for Health Professionals; 2024. [Accessed 2026 March 18]. Available from: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/
Si applica ai prodotti: providing more than 350 mg of magnesium per day.
When using this product you may experience diarrhea (NNHPD 2026).
Fonti citate da Health Canada (2)
- NNHPD 2026: Natural and Non-Prescription Health Products Directorate. Multi-Vitamin/Mineral Supplements monograph. [Accessed 2026 May 29]. Available from: https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=eng
- DPSNSO 2026. Direction des produits de santé naturels et sans ordonnance. Monographies des suppléments de multivitamines et minéraux [Consulté le 29 mai 2026]. Disponible à : https://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq?atid=multi_vitmin_suppl3&lang=fre
- ROYAL JELLY
Leggere l'avvertenza, quando si applica e gli studi citati
Testo originale ufficiale in inglese.
ROYAL JELLY
Via di somministrazione: Oral
Precauzioni e avvertenze
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Controindicazioni
Do not use if you have a history of asthma or allergies (TGA 2001; Leung et al. 1997; Harwood et al. 1996; Laporte et al. 1996; Thien et al. 1996; Leung et al. 1995; Peacock et al. 1995; Bullock 1994).
Fonti citate da Health Canada (8)
- Bullock RJ. Fatal royal-jelly induced asthma. Medical Journal of Australia 1994;160:44. PubMed Caso clinico
- Harwood M, Harding S, Beasley R, Frankish PD. Asthma following royal jelly. The New Zealand Medical Journal 1996;109:325. PubMed Caso clinico
- Laporte JR, Ibaanez L, Vendrell L, Ballarin E. Bronchospasm induced by royal jelly. Allergy 1996;51:440. PubMed
- Leung R, Ho A, Chan J, Choy D, Lai CK. Royal jelly consumption and hypersensitivity in the community. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1997;27(3):333-336. PubMed
- Leung R, Thien FC, Baldo B. Royal Jelly-induced asthma and anaphylaxis: clinical characteristics and immunologic correlations. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1995;96:1004-1007. PubMed Caso clinico
- Peacock S, Muray V, Turton C. Respiratory distress and royal jelly. British Medical Journal 1995;311:1472. PubMed Caso clinico
- TGA 2001: Australian Therapeutic Goods Administration. CMEC 28: Complementary Medicines Evaluation Committee, Extracted Ratified Minutes twenty-eight Meeting, 27-28 July 2001. Australian Government Department of Health and Aging, Sydney, Australia; 2001. [Accessed 2025 February 5]. Available from: https://www.tga.gov.au/sites/default/files/cmec-minutes-28.pdf
- Thien FC, Leung R, Baldo BA, Weiner JA, Plomley R, Czarny D. Asthma and anaphylaxis induced by royal jelly. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1996;26(2):216-222. PubMed
Reazioni avverse note
Stop use if hypersensitivity/allergy occurs (Leung et al. 1997; Laporte et al. 1996; Thien et al. 1996; Leung et al. 1995; Peacock et al. 1995).
Fonti citate da Health Canada (6)
- Laporte JR, Ibaanez L, Vendrell L, Ballarin E. Bronchospasm induced by royal jelly. Allergy 1996;51:440. PubMed
- Leung R, Ho A, Chan J, Choy D, Lai CK. Royal jelly consumption and hypersensitivity in the community. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1997;27(3):333-336. PubMed
- Leung R, Thien FC, Baldo B. Royal Jelly-induced asthma and anaphylaxis: clinical characteristics and immunologic correlations. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1995;96:1004-1007. PubMed Caso clinico
- Peacock S, Muray V, Turton C. Respiratory distress and royal jelly. British Medical Journal 1995;311:1472. PubMed Caso clinico
- Thien FC, Leung R, Baldo BA, Weiner JA, Plomley R, Czarny D. Asthma and anaphylaxis induced by royal jelly. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1996;26(2):216-222. PubMed
- Harwood M, Harding S, Beasley R, Frankish PD. Asthma following royal jelly. The New Zealand Medical Journal 1996;109:325. PubMed Caso clinico
- COENZYME Q10
Leggere l'avvertenza, quando si applica e gli studi citati
Testo originale ufficiale in inglese.
Coenzyme Q10 (UBIQUINONE-10)
Via di somministrazione: Oral
Precauzioni e avvertenze
Condizione di applicazione: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood pressure medication (Rosenfeldt et al. 2007; Singh et al. 1999).
Fonti citate da Health Canada (2)
- Rosenfeldt FL, Haas SJ, Krum H, Hadj A, Ng K, Leong JY, Watts GF. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. Journal of Human Hypertension 2007;21(4):297-306. PubMed Meta-analisi
- Singh RB, Niaz MA, Rastogi SS, Shukla PK, Thakur AS. Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease. Journal of Human Hypertension 1999;13(3):203-208. PubMed Studio randomizzato
Si applica ai prodotti: providing more than 100 mg of Coenzyme Q10 per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Engelsen et al. 2003; Landbo and Almdal 1998; Spigset 1994).
Fonti citate da Health Canada (3)
- Engelsen J, Nielsen JD, Hansen KF. [Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in patients on long-term warfarin treatment. A randomized, double-blind, placebo-controlled cross-over trial]. Ugeskr Laeger 2003;165(18):1868-1871 (in Danish). PubMed Studio randomizzato
- Landbo C, Almdal TP. [Interaction between warfarin and coenzyme Q10]. Ugeskr Laeger 1998;160(22):3226-3227 (in Danish). PubMed Caso clinico
- Spigset O. Reduced effect of warfarin caused by ubidecarenone. Lancet 1994;344(8933):1372-1373. PubMed Caso clinico
Condizione di applicazione: Migraine prophylaxis/prevention.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if migraine frequency increases and associated nausea and vomiting persist or worsen.
Riguardano l'ingrediente, non questo prodotto né la sua dose. Non sostituiscono il parere medico.
La data della prova di questo elenco di ingredienti è sconosciuta.
Il prodotto è cambiato? Fotografi la confezione.
Un'informazione inesatta o più recente su questo prodotto, che lei sia lettore o marca? Scriva a contact@compoatlas.com: ogni correzione è pubblicata nel registro delle correzioni.